News

Medical Marketing & Media2h
Rx Rundown: Eli Lilly, Teva, Vivo Capital and more
NewLimit, an anti-aging biotech startup backed by Coinbase CEO Brian Armstrong, raised a $130 million Series B round.
Cambridge Independent8h
Alchemab Therapeutics signs $415m licensing deal with Eli Lilly
Alchemab Therapeutics has entered into a licensing agreement with Eli Lilly and Company (Lilly) for ATLX-1282, Alchemab’s ...